Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors H. Baas Pages: IV12 - IV16
SPECT and PET imaging of the dopaminergic system in Parkinson's disease T. BrückeS. DjamshidianI. Podreka Pages: IV2 - IV7
Workshop I: Parkinson's disease and sleep – results of the group discussion P. ClarenbachW. GreulichM. Werner Pages: IV34 - IV35
Workshop III: Late motor complications of Parkinson's disease W.H. JostA. Berg-MantkowskiA. Storch Pages: IV38 - IV39
Long-term treatment with dopamine agonists in idiopathic in Parkinson's disease H. Reichmann Pages: IV17 - IV19
Workshop II: “Neuroprotection”– the Lugano consensus P. RiedererT. BrückeB. Winner Pages: IV36 - IV37
Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease H. ReichmannU. SommerP. Vieregge Pages: IV40 - IV41